PATENT CLAIM ANALYSIS

Application Number: 15950065
Application Type: Utility
Filing Date: 2018-04
Publication Date: 2018-09
Patent Classification: ["514", "212040"]

Abstract:
The present disclosure provides crystalline Compound I and crystalline Compound II, pharmaceutical compositions comprising one of said crystalline compounds suitable for intratympanic administration, and methods for treating otic disorders using the crystalline compounds and the pharmaceutical compositions.

Claim (Index 5):
Crystalline Compound II having the formula: characterized by an x-ray powder diffraction pattern with peaks at 8.4, 15.2, 16.0, 20.6, and 22.6\u00b10.15 degrees two-theta.

Metadata:
- Claim Count in Document: 34.0
- Percentile: 91.0
- Lexical Diversity: 1.42857
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['12837286', '13928157', '14469408', '12506616', '11731663']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7244491924092319
- 35 USC 102 Novelty (BERT): 0.5070917828284693
- Combined Prediction Score: 0.7027134514511556
- Mean Citation Score: 244.283842
- Max Citation Score: 256.07574
- Similarity Product: 196.7692583814525

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test